What Are Nucleated Red Blood Cells and What Do They Mean?

Nucleated red blood cells (NRBCs) are immature red blood cells that still contain a nucleus. Mature red blood cells in humans have expelled their nucleus during development in the bone marrow, which is what makes them uniquely flexible and efficient at carrying oxygen. When NRBCs show up in a blood sample from an adult or older child, it almost always signals that something has gone wrong: the body is under enough stress that it is pushing unfinished red blood cells into circulation before they are ready. In newborns, small numbers are normal, but high counts point to oxygen deprivation or other complications. The meaning of NRBCs shifts dramatically depending on who the patient is, how many are present, and whether the count is rising or falling.

How Red Blood Cells Normally Lose Their Nucleus

Every red blood cell begins life in the bone marrow as a nucleated precursor called an erythroblast. As it matures, it undergoes a process called enucleation: the nucleus condenses, migrates to one side of the cell, and is eventually pinched off. This involves a dramatic rearrangement of the cell’s internal scaffolding and interaction with surrounding immune cells called macrophages in specialized bone marrow clusters known as erythroblastic islands.¹ The macrophages essentially help the developing red blood cell eject its nucleus and then clean up the discarded material.

Losing the nucleus is not a defect. It frees up space inside the cell for more hemoglobin (the protein that carries oxygen) and gives the cell its characteristic biconcave disc shape, which lets it squeeze through the narrowest capillaries. This strategy is actually unusual in the animal kingdom. Birds, reptiles, fish, and amphibians all have red blood cells that keep their nuclei throughout their lifespan. Research comparing bird and mammal blood has found that the two groups appear to use different strategies to solve a common problem: delivering oxygen efficiently despite having differently structured red blood cells.²

Under normal conditions in a healthy adult, the process works so smoothly that essentially zero NRBCs make it into the bloodstream. The bone marrow releases only fully mature, nucleus-free red blood cells. When this quality control breaks down, NRBCs spill into circulating blood, and that is what catches a clinician’s attention.

NRBCs in Newborns Are Expected, Up to a Point

Newborns are the big exception to the “NRBCs should not be in the blood” rule. Healthy full-term babies routinely have a small number of NRBCs in their cord blood at birth. One study using automated analyzers found a median of about 3 NRBCs per 100 white blood cells in cord blood from healthy term pregnancies, with some normal babies having up to about 12.³ These counts vary with gestational age and drop rapidly after birth; reference ranges have been established to help clinicians distinguish normal counts from worrisome ones.⁴

The reason newborns have NRBCs at all is that fetal blood production works differently. During early development, blood cells are made outside the bone marrow entirely, in the yolk sac, liver, and spleen.⁵ As the fetus matures, production gradually shifts to the bone marrow, but even at term some immature cells are still circulating. They disappear within the first few days of life as the newborn’s marrow takes over fully.

What High Counts Mean in Newborns

The clinical concern arises when a newborn’s NRBC count is well above the normal reference range, because this strongly suggests the baby experienced oxygen deprivation before or during birth. When fetal tissues become hypoxic, the kidneys ramp up production of erythropoietin, a hormone that tells the bone marrow and liver to accelerate red blood cell production. In the rush to get more oxygen-carrying cells into the bloodstream, immature NRBCs get released before they have had time to shed their nuclei. Research using the timing of erythropoietin’s effects estimated that neonates with elevated NRBC counts at birth had the onset of their hypoxia at least 28 to 29 hours before delivery.⁶

A study comparing asphyxiated newborns to healthy controls found stark differences. Asphyxiated infants had a mean of about 30 NRBCs per 100 white blood cells, compared with roughly 6 in the control group. The NRBC count correlated with Apgar scores, the severity of brain injury staging, and mortality.⁷ Other research found that NRBC counts at birth correlated with gestational age, Apgar scores, blood pH, base deficit, and birth weight, reinforcing the idea that the count reflects how much metabolic stress the baby experienced.⁸

An important practical detail: the NRBC count does not just tell you whether there was a problem. In babies with moderate to severe brain injury from oxygen deprivation, the half-life of NRBCs in the blood was about 60 hours in those with elevated counts, compared with 39 hours in those with normal counts.⁹ In other words, the worse the injury, the longer those immature cells stick around, which can help clinicians gauge severity even after birth.

Pregnancy Complications That Drive Up Fetal NRBCs

It is not just labor and delivery problems that raise fetal NRBC counts. Chronic conditions during pregnancy can create a sustained state of low oxygen for the fetus, and NRBCs reflect this. Preeclampsia, a condition marked by high blood pressure and organ damage in the mother, is one of the most studied triggers. In pregnancies complicated by preeclampsia, cord blood NRBC counts were dramatically higher than in normal pregnancies. One study found a mean of about 40 NRBCs per 100 white blood cells in the preeclampsia group versus roughly 6 in controls.¹⁰ A cord blood NRBC count of 13 or fewer could rule out adverse outcomes with high specificity. Another study found that about 64% of mothers with preeclampsia had newborns with abnormally elevated NRBC levels, compared to only about 3% in the normal group.¹¹

Maternal diabetes is another culprit. Babies born to diabetic mothers had nearly three times the NRBC counts of babies born to non-diabetic mothers, alongside lower blood pH and higher carbon dioxide levels suggesting chronic intrauterine acidosis.¹² The mechanism is similar: the placenta in a diabetic pregnancy may not deliver oxygen as efficiently, so the fetus compensates by boosting red blood cell production, and immature NRBCs are the byproduct.

A Danger Signal in Critically Ill Adults

In adults beyond the newborn period, NRBCs in the bloodstream are rare and almost never benign. Healthy adults simply do not have them. When they appear, the body is either under extreme physiological stress (causing the bone marrow to dump immature cells into circulation) or the bone marrow itself has been disrupted by disease.

The prognostic implications are striking. In a prospective study of medical intensive care patients, about 18% had detectable NRBCs. Among those NRBC-positive patients, the mortality rate was roughly 51%, compared with about 10% in those without NRBCs. Mortality climbed steeply with increasing NRBC concentration: nearly 79% of patients with counts above 200 per microliter died. Even after adjusting for other laboratory and clinical risk factors, each step up in the NRBC category roughly doubled the odds of death.¹³

In cardiac ICU patients specifically, the presence of NRBCs was associated with in-hospital mortality of about 61% versus 33% for NRBC-negative patients. After adjusting for illness severity scores, sex, and sepsis, NRBCs remained independently associated with death, with roughly four-fold higher odds.¹⁴ Among patients admitted specifically for ST-elevation heart attacks, the contrast was even more dramatic: mortality was 63% in those with positive NRBCs versus about 8% in those without. The NRBC count outperformed standard ICU severity scoring systems in predicting death, with a sensitivity and specificity both above 80%.¹⁵

Severe burns with sepsis represent another setting where NRBCs have been flagged as early warning indicators.¹⁶ The thread running through all these settings is the same: the body is in crisis, the bone marrow is working overtime or being disrupted, and the appearance of NRBCs is a measurable sign of that crisis.

Why Trends Matter More Than a Single Number

A single NRBC measurement tells you something is wrong. Repeated measurements tell you whether the patient is getting better or worse, and this turns out to be at least as important. In surgical ICU patients, rising NRBC counts were associated with increasing mortality, but patients whose NRBCs dropped back to zero had outcomes similar to patients who never had NRBCs at all.¹⁷ The same pattern has been confirmed in other ICU populations: once NRBCs disappeared from the blood during the course of treatment, mortality dropped back to the level of NRBC-negative patients.¹⁸

The practical takeaway for clinicians is that NRBCs should not be checked once and forgotten. Tracking them over time provides a dynamic window into whether the underlying stress is resolving or worsening. Patients whose NRBCs persist or rise need aggressive reassessment. Patients whose counts are declining are, broadly speaking, heading in the right direction. Review articles on the topic have emphasized this trajectory-based approach, noting that elevation in NRBC levels correlated with mortality while a decrease to undetectable values appeared to be protective.¹⁹

Conditions That Can Release NRBCs Into Adult Blood

The causes of NRBCs in adult peripheral blood fall into a few broad categories, and understanding them helps explain why the finding is so ominous. The common thread is that something is either pushing the bone marrow into overdrive or directly disrupting its architecture.

Severe hypoxia: Massive blood loss, shock, respiratory failure, or heart failure can starve tissues of oxygen, triggering an erythropoietin surge that forces immature cells out before they mature.
Bone marrow infiltration: Cancers that invade the bone marrow (leukemia, lymphoma, metastatic solid tumors) physically disrupt the normal barriers that keep immature cells from escaping. Myelofibrosis, where the marrow becomes scarred and stiff, has a similar effect. This pattern is sometimes called a leukoerythroblastic blood picture, where both immature white and red blood cells spill into the circulation.
Extramedullary hematopoiesis: When the bone marrow fails, the body may revert to producing blood cells in the liver or spleen, as it did during fetal life. These alternate sites are less controlled, and NRBCs are more likely to enter the bloodstream from them.
Severe sepsis and systemic inflammation: Overwhelming infection can both increase erythropoietin drive and directly damage the bone marrow’s filtering mechanisms.

Any of these mechanisms can operate alone or in combination. A patient with metastatic cancer, sepsis, and organ failure may have NRBCs for multiple overlapping reasons, which helps explain why the finding correlates so strongly with mortality: it often appears when several catastrophic processes are happening at once.

The Lab Side of NRBCs

Detecting NRBCs used to require a pathologist or technician to examine a stained blood smear under a microscope and manually count them. Modern automated hematology analyzers have changed this. Machines like the Sysmex XN series can identify NRBCs as a distinct population by lysing mature red blood cells and measuring the fluorescence of remaining nucleated cells. In children under one year of age, where NRBC counts can be very high, automated counts correlated strongly with manual microscopy up to about 200 NRBCs per 100 white blood cells.²⁰ At extremely high counts, the variation between automated and manual methods increases, but for routine clinical use, automated counting has largely replaced the labor-intensive manual approach.

One important laboratory pitfall deserves attention. Because NRBCs are nucleated, many hematology analyzers mistake them for white blood cells. If the analyzer does not have a dedicated NRBC channel, the reported white blood cell count will be falsely elevated by the NRBCs mixed in. This matters in clinical decision-making: a doctor relying on an inflated white blood cell count might suspect infection when the real issue is a large number of NRBCs. A manual correction has traditionally been needed in these cases, and knowing when to apply it remains a practical concern.²¹

NRBCs for Telling Heart Disease From Lung Disease in Newborns

An intriguing clinical application of NRBC counts is in newborns who are blue at birth. Both congenital heart disease and respiratory disease can cause cyanosis, but the underlying mechanisms are different, and so is the NRBC response. Babies with respiratory disease had much higher NRBC counts in the first 12 hours of life than babies with congenital heart disease, despite the heart disease group actually having lower oxygen saturations. A cutoff of about 1,070 NRBCs per cubic millimeter could distinguish between the two with a positive predictive value of 0.94.²² The likely explanation is that respiratory disease causes acute tissue hypoxia that triggers a rapid erythropoietin response, while congenital heart defects cause a different type of oxygen delivery problem, often chronic and compensated, that does not spike NRBCs to the same degree in the immediate postnatal period.

Fetal NRBCs and Prenatal Testing

Because fetal blood naturally contains NRBCs and maternal blood does not, a small number of fetal NRBCs that cross the placenta into the mother’s bloodstream offer a tantalizing target for non-invasive prenatal diagnosis. Each fetal NRBC carries the complete fetal genome, making it potentially more informative than the fragments of cell-free fetal DNA currently used in standard non-invasive screening.²³

The challenge has always been rarity. Fetal NRBCs are vanishingly scarce in maternal blood, and separating them from the overwhelming number of maternal cells requires sophisticated enrichment techniques. Researchers have developed methods using molecular tools called aptamers that can selectively bind to fetal NRBCs and pull them out of a maternal blood sample.²⁴ Other groups have used microfluidic chip-based approaches that combine multiple enrichment steps, successfully isolating fetal NRBCs from just one milliliter of maternal blood and confirming fetal origin by detecting Y-chromosome genes.²⁵ The technology is not yet in routine clinical use, but it represents a potential upgrade over current screening methods because it could provide a complete fetal genetic picture from a simple maternal blood draw, without the miscarriage risk of amniocentesis.

NRBCs in Forensic Investigation

Outside the hospital, NRBC counts have found a role in forensic pathology, particularly in investigating sudden unexpected infant deaths. In cases where the cause of death is unclear, postmortem NRBC levels can provide clues about whether the infant experienced chronic or acute hypoxia before death. A study of 139 infant deaths found that NRBC levels were significantly increased in babies who were born prematurely, in those with underlying medical conditions, and in deaths related to identifiable illness or trauma. There was also a trend toward higher NRBCs in younger infants and in babies whose mothers smoked during pregnancy.²⁶ This does not provide a definitive cause of death on its own, but it adds a piece of objective physiological evidence to what is often a complex and emotionally charged investigation.

Animal research has helped clarify the dose-response relationship between hypoxia duration and NRBC counts. In a rat model, fetal NRBC counts rose in a clear stepwise pattern as hypoxia duration increased, becoming statistically significant after 24 hours. After 48 hours, counts were about 2.5 times normal; after 120 hours, they were about 4.5 times normal.²⁷ This kind of graded response makes NRBCs useful not just for detecting that hypoxia happened, but for estimating how long it lasted, which has obvious implications for both clinical and forensic settings.